Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled

Serhat Karadag1, Savas Ozturk2, Mustafa Arici3

  • 1Department of Nephrology, University of Health Sciences, Haseki Training and Research Hospital, Istanbul, Turkey.

Insights

Patients with chronic kidney disease (CKD) who survived COVID-19 experienced higher mortality and worsening kidney function post-infection. This study highlights the significant long-term risks of COVID-19 for CKD patients not on dialysis.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • Chronic kidney disease (CKD) is a known risk factor for severe outcomes and mortality in Coronavirus disease 2019 (COVID-19).
  • Limited research exists on the post-COVID-19 prognosis for CKD patients, particularly those not requiring renal replacement therapy.
  • Understanding these outcomes is crucial for managing CKD patients during and after the pandemic.

Purpose of the Study:

  • To investigate the outcomes of CKD patients after surviving COVID-19.
  • To compare the post-COVID-19 period in CKD patients with a control group of CKD patients who did not contract COVID-19.
  • To assess kidney function, respiratory symptoms, dialysis requirements, and mortality rates.

Main Methods:

  • A multicenter observational study included CKD patients (GFR < 60 ml/min/1.73 m²) who survived COVID-19.
  • Exclusion criteria included CKD caused by diabetic nephropathy, polycystic kidney disease, and glomerulonephritis.
  • A control group of CKD patients with similar characteristics but no COVID-19 infection was used for comparison.

Main Results:

  • The COVID-19 group (173 patients) showed significantly higher creatinine levels at 1 month post-infection compared to the control group (207 patients).
  • Respiratory symptoms were more prevalent in the COVID-19 group at 1 and 3 months post-diagnosis.
  • Mortality at 3 months (5.2% vs. 1.4%) and the need for dialysis (8.1% vs. 3.4%) were significantly higher in the COVID-19 survivors.

Conclusions:

  • COVID-19 infection is associated with increased mortality in CKD patients.
  • Survivors of COVID-19 with CKD experience significant deterioration in kidney function and an increased need for dialysis post-infection.
  • CKD patients who contract COVID-19 are at higher risk for persistent respiratory symptoms.
Abstract

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
75
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
76
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
74
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
60
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
50
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
55